<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01984346</url>
  </required_header>
  <id_info>
    <org_study_id>VAL-1200</org_study_id>
    <secondary_id>IDE Number G130084</secondary_id>
    <nct_id>NCT01984346</nct_id>
  </id_info>
  <brief_title>CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)</brief_title>
  <acronym>CONVERGE</acronym>
  <official_title>Convergence Of Epicardial And Endocardial Radiofrequency (RF) Ablation For The Treatment Of Symptomatic Persistent AF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, open label, randomized pivotal study evaluating the safety and&#xD;
      efficacy of the EPi-Sense-AF Guided Coagulation System for the treatment of persistent AF&#xD;
      patients, refractory or intolerant to at least one Class I and/or III Anti Arrhythmic Drug&#xD;
      (AAD).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this randomized pivotal study is to evaluate the safety and efficacy of the&#xD;
      AtriCure EPi-Sense®-AF Guided Coagulation System with VisiTrax® for the treatment of&#xD;
      symptomatic persistent Atrial Fibrillation (AF) patients, refractory or intolerant to at&#xD;
      least one Class I or Class III anti-arrhythmic drug (AAD). 153 subjects from up to 27 US and&#xD;
      3 OUS sites. Randomized 2:1.&#xD;
&#xD;
      The primary efficacy endpoint is success or failure to be AF/AT/AFL free absent class I and&#xD;
      III AADs except for a previously failed or intolerant class I or III AAD with no increase in&#xD;
      dosage following the 3-month blanking period through the 12-month post procedure follow-up&#xD;
      visit.&#xD;
&#xD;
      The primary safety endpoint is the incidence of major adverse events (MAEs) listed in the&#xD;
      protocol for subjects undergoing the convergent procedure for the procedural to 30-day post&#xD;
      procedure time period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Actual">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2:1 randomized (Convergent Procedure versus standalone endocardial catheter ablation) multi-center pivotal clinical study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AF/AT/Atrial Flutter(AFL) free absent class I and III AADs except for a previously failed or intolerant class I or III AAD with no increase in dosage.</measure>
    <time_frame>12 Months</time_frame>
    <description>The primary efficacy endpoint is success or failure to be AF/AT/AFL free absent class I and III AADs except for a previously failed or intolerant class I or III AAD with no increase in dosage following the 3 month blanking period through the 12 months post procedure follow-up visit.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Convergent Procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Convergent Procedure using EPi-Sense-AF Guided Coagulation System with Endocardial Catheter Ablation Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standalone Endocardial Catheter Ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endocardial Catheter Ablation Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax</intervention_name>
    <description>Convergent Epicardial Endocardial Ablation Procedure</description>
    <arm_group_label>Convergent Procedure</arm_group_label>
    <other_name>Epicardial EPi-Sense-AF Guided Coagulation System combined with endocardial RF catheter ablation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering</intervention_name>
    <description>Endocardial Catheter Ablation only</description>
    <arm_group_label>Convergent Procedure</arm_group_label>
    <arm_group_label>Standalone Endocardial Catheter Ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years; &lt; 80 years&#xD;
&#xD;
          -  Left atrium &lt; 6.0 cm&#xD;
&#xD;
          -  Refractory or intolerant to one AAD (class I and/or III)&#xD;
&#xD;
          -  Documentation of persistent AF&#xD;
&#xD;
          -  Provided written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring concomitant surgery&#xD;
&#xD;
          -  Left ventricular ejection fraction &lt; 40%&#xD;
&#xD;
          -  Pregnant or planning to become pregnant during study&#xD;
&#xD;
          -  Co-morbid medical conditions that limit one year life expectancy&#xD;
&#xD;
          -  Previous cardiac surgery&#xD;
&#xD;
          -  History of pericarditis&#xD;
&#xD;
          -  Previous cerebrovascular accident (CVA), excluding fully resolved transient Ischemic&#xD;
             attack (TIA)&#xD;
&#xD;
          -  Patients who have active infection or sepsis&#xD;
&#xD;
          -  Patients with esophageal ulcers strictures and varices&#xD;
&#xD;
          -  Patients with renal dysfunction who are not on dialysis&#xD;
&#xD;
          -  Patients who are contraindicated for anticoagulants&#xD;
&#xD;
          -  Patients who are being treated for ventricular arrhythmias&#xD;
&#xD;
          -  Patients who have had a previous left atrial catheter ablation for AF&#xD;
&#xD;
          -  Patients with existing Implantable Cardioverter-Defibrillator (ICDs)&#xD;
&#xD;
          -  Current participation in another clinical investigation of a medical device or a drug,&#xD;
             or recent participation in such a study within 30 days prior to study enrollment&#xD;
&#xD;
          -  Not competent to legally represent him or herself&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David DeLurgio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory St Joseph's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grandview Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center Research LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rose Medical Center / Medical Center of Aurora</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's HealthCare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mt Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palm Beach Gardens Medical Center</name>
      <address>
        <city>Palm Beach Gardens</city>
        <state>Florida</state>
        <zip>33410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University - St. Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Group Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Foundation of Louisiana</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Regional Medical Center</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Research, LLC</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Staten Island University Hospital</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Carolina University - Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Medical Center / Cary Research Group</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Health System</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Hospital / OhioHealth</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle Hospitals</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny-Singer Research Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart PLLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>STAR Clinical Trials LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Cardiovascular Specialists</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Bartholomew's Hospital</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>November 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2013</study_first_posted>
  <disposition_first_submitted>August 18, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>August 25, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">September 1, 2020</disposition_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Convergent Procedure</keyword>
  <keyword>Combined Epicardial/ Endocardial Ablation</keyword>
  <keyword>Hybrid Procedure</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Arrhythmia</keyword>
  <keyword>RF Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>August 12, 2021</submitted>
    <returned>September 8, 2021</returned>
    <submitted>October 20, 2021</submitted>
    <returned>November 18, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

